Pharma news
Americas
Bayer and two Boston hospitals have joined forces in a chronic lung disease research product, with the trio championing the ‘joint lab’ model as a blueprint for pharmaceutical research. 26 September 2019
Americas
A former pharmaceutical CEO was last Thursday sentenced to 33 months in prison by an Indiana federal court for distributing “adulterated” drugs, including sedatives and opioids which were administered to infants. 23 September 2019
Americas
The Biotechnology Innovation Organization has claimed that if the drug pricing plan unveiled by US House of Representatives Speaker Nancy Pelosi yesterday, September 19, becomes law, it will upend the US’s ability to lead the world in biomedical innovation. 20 September 2019
Pharma
A group of senators has urged the US Federal Trade Commission to closely scrutinise mergers in the pharmaceutical industry, which it said “increase competition issues and stifle innovation”. 19 September 2019
Americas
A US judge dismissed antitrust counterclaims brought against Allergan and Duke University earlier this week, in a lawsuit the pair filed against generics maker Akorn. 19 September 2019
Pharma
This week at the AIPPI World Congress 2019, counsel discussed how supplementary protection certificates and patent term extension regulations differ across jurisdictions. 17 September 2019
Pharma
The Court of Justice of the European Union last week issued its decision in a case concerning whether a ‘launch at risk’ bars compensation for a wrongfully issued preliminary injunction. 17 September 2019
Pharma
A district court has upped Vectura’s award of $89.7 million in damages by $10m, after a jury trial earlier this year found that GlaxoSmithKline has willfully infringed one of its patents. 16 September 2019
Pharma
The Trump administration has pledged to crack down on the sale of unauthorised vape products, amid growing public health concerns over the safety of e-cigarettes. 12 September 2019
Americas
Taiwanese company JHL Biotech will stop developing biosimilar versions of Genentech’s drugs as part of a memorandum of understanding signed by the parties to end trade secrets litigation. 10 September 2019